Discordant HER2/Neu Status of Breast Cancer.

计划入组 105 人 · 首次发布于 2013 年 9 月 5 日

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

计划入组 33 人 · 首次发布于 2012 年 11 月 21 日

Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers

计划入组 24 人 · 首次发布于 2004 年 11 月 9 日

Ii-Key-HER2,neu

li-Key-HER2/neu

HER2/neu peptide vaccine

Neuren Pharmaceuticals Ltd

Northeastern University

United States

Zymeworks

Canada

FDA Approves Roche's Companion Diagnostic for HER2-Targeted Therapy in Biliary Tract Cancer

FDA Approves Roche's PATHWAY HER2 Test as Companion Diagnostic for Biliary Tract Cancer

Greenwich LifeSciences' GLSI-100 Receives FDA Fast Track Designation for HER2-Positive Breast Cancer Prevention